Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study

Biomed Res Int. 2014:2014:324307. doi: 10.1155/2014/324307. Epub 2014 Dec 7.

Abstract

Blood and plasma viscosity are the major factors affecting blood flow and normal circulation. Whole blood viscosity is mainly affected by plasma viscosity, red blood cell deformability/aggregation and hematocrit, and other physiological factors. Thirty patients (twenty males + ten females) with age range 50-65 years, normotensive with history of cerebrovascular disorders, were selected according to the American Heart Stroke Association. Blood viscosity and other rheological parameters were measured after two-day abstinence from any medications. Dual effects of vinpocetine and pyritinol exhibit significant effects on all hemorheological parameters (P < 0.05), especially on low shear whole blood viscosity (P < 0.01), but they produced insignificant effects on total serum protein and high shear whole blood viscosity (P > 0.05). Therefore, joint effects of vinpocetine and pyritinol improve blood and plasma viscosity in patients with cerebrovascular disorders.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Blood Proteins / biosynthesis
  • Blood Viscosity / drug effects*
  • Cerebrovascular Disorders / blood
  • Cerebrovascular Disorders / drug therapy*
  • Cerebrovascular Disorders / physiopathology
  • Drug Synergism
  • Erythrocytes
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pyrithioxin / administration & dosage*
  • Randomized Controlled Trials as Topic
  • Rheology
  • Vinca Alkaloids / administration & dosage*

Substances

  • Blood Proteins
  • Vinca Alkaloids
  • vinpocetine
  • Pyrithioxin